Proscia is a digital pathology software company building the Concentriq enterprise platform to connect discovery through diagnosis with AI. Concentriq unifies data, teams, and apps so pathologists and scientists can manage whole-slide images, run AI, and collaborate across clinical and life-sciences workflows; tailored products include Concentriq AP/AP-Dx for diagnostics and Concentriq LS for therapeutic R&D.

The company has secured key regulatory milestones—FDA 510(k) clearance for Concentriq AP-Dx and CE-IVDR certification for Concentriq Dx—supporting adoption across global health systems. It reports rapid growth and scale, counting many leading pharma companies as users and handling tens of thousands of patient diagnoses per day on its software. Recent updates include a $50M funding round and expanded cloud collaboration to accelerate precision medicine.